Repare Therapeutics (RPTX) Stock Chart & Stock Price History → With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (From Stocks News) (Ad) Free RPTX Stock Alerts $3.69 -0.01 (-0.27%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Repare Therapeutics Stock Price Performance5 Day Performance+5.43%1 Month Performance+6.34%3 Month Performance-46.91%6 Month Performance-30.25%Year-To-Date Performance-49.45%1 Year Performance-63.61% Receive RPTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Repare Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyAmerica’s worst nightmare?What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. RPTX Stock Chart for Wednesday, May, 15, 2024 RPTX Chart by TradingView Repare Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$3.70$3.69-0.27%$3.88$3.69254,879 shs$156.60 million05/13/2024$3.50$3.70+5.71%$3.89$3.56301,388 shs$157.03 million05/10/2024$3.64$3.50-3.85%$3.75$3.50287,255 shs$148.56 million05/09/2024$3.79$3.64-3.96%$3.95$3.52724,875 shs$154.48 million05/08/2024$3.28$3.79+15.55%$3.96$3.564.57 million shs$160.85 million05/07/2024$3.40$3.28-3.53%$3.46$3.2659,489 shs$139.20 million Get the Latest News and Ratings for RPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Repare Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$3.45$3.40-1.45%$3.59$3.39118,440 shs$144.30 million05/03/2024$3.35$3.45+2.99%$3.74$3.44173,798 shs$146.42 million05/02/2024$3.30$3.35+1.52%$3.57$3.30131,797 shs$142.17 million05/01/2024$3.10$3.30+6.45%$3.49$3.09203,867 shs$140.05 million04/30/2024$3.20$3.10-3.13%$3.22$3.06166,417 shs$114.70 million04/29/2024$3.20$3.20$3.29$3.15102,322 shs$118.40 million04/26/2024$3.15$3.20+1.59%$3.24$3.1171,408 shs$118.40 million04/25/2024$3.30$3.15-4.55%$3.26$3.1182,157 shs$116.55 million04/24/2024$3.36$3.30-1.79%$3.42$3.2672,908 shs$122.10 million04/23/2024$3.26$3.36+3.07%$3.43$3.24175,602 shs$124.32 million04/22/2024$3.15$3.26+3.49%$3.40$3.09109,320 shs$120.62 million04/19/2024$3.02$3.15+4.30%$3.28$2.98219,182 shs$116.55 million04/18/2024$3.21$3.02-5.92%$3.25$3.00139,430 shs$111.74 million04/17/2024$3.34$3.21-3.89%$3.37$3.1679,291 shs$118.77 million04/16/2024$3.47$3.34-3.75%$3.47$3.2485,215 shs$123.58 million04/15/2024$3.65$3.47-4.93%$3.71$3.3589,849 shs$128.39 million04/12/2024$3.90$3.65-6.41%$3.98$3.6194,021 shs$135.05 million04/11/2024$3.94$3.90-1.02%$4.00$3.8177,431 shs$144.30 million04/10/2024$3.94$3.94$4.05$3.69151,263 shs$145.78 million04/09/2024$4.04$3.94-2.48%$4.14$3.9156,281 shs$145.78 million04/08/2024$3.98$4.04+1.51%$4.14$3.9362,681 shs$149.48 million04/05/2024$3.90$3.98+2.05%$4.12$3.8297,170 shs$147.26 million04/04/2024$4.11$3.90-5.11%$4.20$3.82117,777 shs$144.30 million04/03/2024$4.35$4.11-5.52%$4.42$3.99164,548 shs$152.07 million04/02/2024$4.70$4.35-7.45%$4.65$4.26109,566 shs$160.95 million04/01/2024$4.71$4.70-0.21%$4.77$4.51182,262 shs$173.90 million03/29/2024$4.71$4.71$4.88$4.35247,681 shs$174.27 million03/28/2024$4.67$4.71+0.86%$4.88$4.35247,679 shs$174.27 million03/27/2024$4.53$4.67+3.09%$4.77$4.51116,847 shs$196.98 million03/26/2024$4.76$4.53-4.83%$4.89$4.52129,313 shs$191.08 million03/25/2024$4.89$4.76-2.66%$4.97$4.7259,621 shs$200.78 million03/22/2024$5.20$4.89-5.96%$5.38$4.7972,816 shs$206.26 million03/21/2024$5.27$5.20-1.33%$5.52$5.1953,609 shs$219.34 million03/20/2024$5.24$5.27+0.57%$5.36$4.9973,776 shs$222.29 millionThe 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. 03/19/2024$5.17$5.24+1.35%$5.48$5.1564,454 shs$221.02 million03/18/2024$5.29$5.17-2.27%$5.33$5.1145,782 shs$218.07 million03/15/2024$5.22$5.29+1.34%$5.66$5.26122,669 shs$223.13 million03/14/2024$5.40$5.22-3.33%$5.36$5.0858,795 shs$220.18 million03/13/2024$5.25$5.40+2.86%$5.56$5.1940,318 shs$227.77 million03/12/2024$5.38$5.25-2.42%$5.42$5.0961,636 shs$221.46 million03/11/2024$5.85$5.38-8.03%$6.03$5.3174,849 shs$226.93 million03/08/2024$6.00$5.85-2.50%$6.08$5.58140,176 shs$246.75 million03/07/2024$6.04$6.00-0.66%$6.33$5.86119,717 shs$254.78 million03/06/2024$6.59$6.04-8.35%$6.73$5.99122,637 shs$254.77 million03/05/2024$6.62$6.59-0.45%$6.91$6.4596,392 shs$277.97 million03/04/2024$7.20$6.62-8.06%$7.28$6.6070,853 shs$279.23 million03/01/2024$6.95$7.20+3.60%$7.45$6.95115,676 shs$303.34 million02/29/2024$6.60$6.95+5.30%$7.26$6.76128,425 shs$292.80 million02/28/2024$6.66$6.60-0.90%$6.76$6.38121,037 shs$278.06 million02/27/2024$6.62$6.66+0.60%$6.97$6.51121,521 shs$280.59 million02/26/2024$6.34$6.62+4.42%$6.75$6.38126,664 shs$278.90 million02/23/2024$6.26$6.34+1.28%$6.39$6.1366,976 shs$267.10 million02/22/2024$6.15$6.26+1.79%$6.54$6.1299,124 shs$259.10 million02/21/2024$6.28$6.15-2.07%$6.34$5.9485,634 shs$259.10 million02/20/2024$6.63$6.28-5.28%$6.76$6.2678,679 shs$264.58 million02/19/2024$6.63$6.63$6.92$6.26169,800 shs$279.32 million02/16/2024$6.95$6.63-4.60%$6.91$6.26169,844 shs$279.32 million02/15/2024$6.81$6.95+2.06%$7.29$6.9192,421 shs$292.80 million02/14/2024$7.10$6.81-4.08%$7.49$6.73189,815 shs$286.91 million Related Companies: DiaMedica Therapeutics Stock Price Chart PDS Biotechnology Stock Price Chart Sagimet Biosciences Stock Price Chart Syros Pharmaceuticals Stock Price Chart FibroGen Stock Price Chart Adicet Bio Stock Price Chart Amylyx Pharmaceuticals Stock Price Chart Regulus Therapeutics Stock Price Chart Nuvectis Pharma Stock Price Chart InterCure Stock Price Chart Receive RPTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Repare Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RPTX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repare Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.